Many with peripheral neuropathy use medications like Gabapentin, Lyrica, or Cymbalta for relief, but these only mask symptoms instead of treating the cause. While they may temporarily reduce pain, ...

Many people are skeptical about chiropractic care at first because they are unaware of what neuropathy treatments are and the ...

DelveInsight's,“ Multifocal Motor Neuropathy Pipeline Insight, 2025 ” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Multifocal Motor Neuropathy pipeline landscape.

LONDON--(BUSINESS WIRE)--The global diabetic neuropathy drugs market is expected to post a CAGR of more than 6% during the period 2019-2023, according to the latest market research report by Technavio ...

DUBLIN--(BUSINESS WIRE)--The "Global Diabetic Neuropathy Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. The global diabetic neuropathy market value ...

New York, USA, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Chemotherapy-induced Peripheral Neuropathy Treatment Market Poised for Strong Growth Throughout the Forecast Period (2025–2034) Amid Rising ...

The rising awareness about diabetic neuropathy is one of the prominent factors likely to contribute to the diabetic neuropathy drugs market growth in the forthcoming years. Several awareness programs ...

Chemotherapy has long forced patients to choose between fighting their cancer and living with nerve pain that can linger for ...

HOUSTON- Dr. Brian Anderson visited the Great Day Houston set to discuss neuropathy, what causes it, as well as how to the treatment option offered by Blueprint to Neuropathy of Houston can remove the ...

(MENAFN- GlobeNewsWire - Nasdaq) The chemotherapy-induced peripheral neuropathy market is emerging as a high-value market opportunity driven by the lack of approved therapies and the significant unmet ...